Ignite Creation Date:
2024-05-06 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03595592
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-06
First Post:
2018-07-11
Brief Title:
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Sponsor:
Fondazione Michelangelo
Organization:
Fondazione Michelangelo
Organization Data
Organization:
Fondazione Michelangelo
Class:
OTHER
Study ID:
FM-17-B01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fondazione Michelangelo
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |